BP000176-C040: Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Protein
Source: p.pichia-derived.
The ED50 as determined by the dose-dependant stimulation of the proliferation of human TF-1 cells (human erythroleukemic indicator cell line) is less then 0.2 ng/ml, corresponding to a Specific Activity of 5.0 x 106 IU/ mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP000157-C050: Recombinant Human Interleukin-4 (IL-4) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependent stimulation of TF-1 cells is less than 2 ng/ml, corresponding to a Specific Activity of 5.0 x 106 IU/mg.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP001429-CA23: Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor Subunit alpha (GMCSFRα) Protein
Source: HEK 293-derived.
Purity: > 95% by reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).PA005211-ANT-107: IL-4 Monoclonal Antibody
Mouse Monoclonal Antibody;
Applications: WB, IP, ELISA, IHC, Intracellular staining;
Reactivity: Human;
Clone: NYRhIL4;
Isotype: Mouse IgG2a Purification MethodIon exchange.PA005211-ANT-108: IL-4 Monoclonal Antibody
Rat Monoclonal Antibody;
Applications: WB, IP, ELISA, IHC, Intracellular staining;
Reactivity: Mouse;
Clone: NYRmIL-4;
Isotype: IgG1.BP000136-CYT-375: Recombinant Mouse IL-13
Source: E. coli-derived.
A single, non-glycosylated polypeptide chain containing 110 amino acids and having a molecular mass of 12 kDa.
The ED50 range=2-6 ug/ml corresponding to a specific activity of 0.17-0.5 MU/mg, determined by the dose dependent prolifiration of TF-1 cells.
Purity > 95%, by SDS-PAGE.BP000136-CYT-391: Recombinant Rat IL-13
Source: E. coli-derived.
Determined by the dose-dependent stimulation of the proliferation of human umbilical vein endothelial cells (HUVEC) using a concentration range of 10-100 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity > 95%, by SDS-PAGE.BP000136-CYT-446: Recombinant Human IL-13
Source: E. coli-derived.
The ED50 was determined by the dose dependent prolifiration of TF-1 cells and was found to be < 1 ug/ml, corresponding to a specific activity of 1 MIU/mg.
Purity > 95%, by SDS-PAGE and RP-HPLC.BP000136-CYT-489: Recombinant Human IL-13, His Tag
Source: E. coli-derived.
Purity > 95%, by SDS--PAGE and RP-HPLC.BP000136-CYT-682: Recombinant Human IL-13 Variant
Source: E. coli-derived.
The ED50 was determined by the dose dependent prolifiration of TF-1 cells and was found to be < 1 ug/ml, corresponding to a specific activity of >1,000,000 units/mg. This analog has also been shown to exhibit increased in vivo activity compared to wild type IL-13.
Purity > 95%, by SDS--PAGE and RP-HPLC.